Development

Jacqueline Liu

Jacqueline Liu M.B., B.Ch.

Regional Head of Clinical Development, Taiwan and Korea

  • Former Medical Advisor & Director of Translational Research Center, ISO17025 certified, TTY Biopharm, with 9 years pharmaceutical development experience
  • Former assistant Principle Investigator & Attending Physician, Institute of Cancer Research, National Health Research Institutes, Taiwan, with over 70 publications
  • Hematology & Medical Oncology Fellow, Medical Residency, Taipei Veterans General Hospital
  • Visiting Scientist, Investigational Drug Branch, NCI, NIH
  • Internship, Chris Hani Baragwanath Hospital, Johannesburg, South Africa
  • University of the Witwatersrand Medical School, MB BCh., South Africa
alicekang

Alice Kang M.D., Ph.D.

Head of Clinical Development, China

  • 9 years academic working experience both in clinical practice and basic research
  • 10 years industry experience both in Medical Affairs and Product Development
  • Formal Senior PD Medical Director, Deputy Site Head for Roche Product Development Oncology_Shanghai Team
  • PH.D, Duisburg-Essen University-Hospital, Essen, Germany
  • Master of Medicine, Gynecologic Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
  • Bachelor, Clinical Medicine, Sun Yat-Sen University of Medical Science
Ross Pettit

Ross Pettit

Head of Global Development Operations

  •  More than 30 years of experience in the pharmaceutical industry
  •  Formerly Senior Vice President of Development Operations at Infinity Pharmaceuticals
  •  Formerly Vice President Clinical Operations AMAG Pharmaceuticals
  •  Formerly Vice President Clinical Operations and Data Management at ARIAD Pharmaceuticals
  •  Formerly Vice President Clinical Operations at Coley Pharmaceutical Group
  •  Formerly held positions in Serono, Otsuka Pharmaceuticals, Parexel International
  •  Master of Business Administration in Healthcare Management from the University of Phoenix
  •  Bachelor of Applied Sciences from University of Kingston, London, U.K.
James Song, Ph.D

James Song, Ph.D.

Head of Biometry

  • Twenty years of academic and industry experience in biostatistics
  • Former Director of Biostatistics, Eisai
  • Former Statistical Leader, Roche
  • Former Associate Director of Biostatistics, Bayer
  • Former Instructor, Baylor College of Medicine
  • Ph.D. in Biometry from University of Texas, School of Public Health in Houston
Alice Tian, M.D., Ph.D, DABT., Senior Director of Non-Clinical Development

Alice Tian, M.D., Ph.D, DABT.

Head of Non-Clinical Development

  • Former Vice President of Drug Development at BL Pharmaceuticals
  • Deputy of Facility Manager at JOINN Laboratories
  • Study Director at MPI Research
  • Study Director and PCR Lab Supervisor at Southern Research Institute
  • Post-Doctoral, Hypertension Program of UAB
  • Ph.D., College of Pharmacy, University of Georgia
  • M.S. Institute of Materia Medica, Chinese Academy of Sciences
  • M.D. Beijing Medical College
Lai Wang, Ph.D. Head of Discovery Biomarkers & In Vivo Pharmacology

Lai Wang, Ph.D.

Head of China Development

  • Former Director of Research at Joyant Pharmaceuticals, where he led a multidisciplinary team working on preclinical oncology programs
  • Post-doc with Xiaodong Wang at Howard Hughes Medical Institute
  • Ph.D. from University of Texas Health Science Center at San Antonio
  • B.S. from Fudan University in 1996
Wendy Yan, Senior Vice President, Head of Regulatory Affairs

Wendy Yan

Head of Regulatory Affairs

  • More than 18 years of regulatory affairs experience at a number of multinational companies
  • Former Director, Head of Regulatory Affairs China, Global Regulatory Strategist at Bayer Healthcare Global R&D Center
  • Director, Head of Regulatory Affairs at GlaxoSmithKline Pharmaceuticals China
  • Senior Regulatory Affairs Manager at AstraZeneca
  • M.B.A. at Staffordshire University
  • Bachelor of Medicine at Beijing Traditional Medicine University
  • Licensed pharmacist